All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The steady maturation of several preclinical development programs has prompted Oxford BioTherapeutics Ltd. to establish a clinical development unit, which it is locating in Basel, Switzerland.
